IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.43M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in IGC Pharma, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +3 vs. Q1 2026
- Shares held
- 5.25M
- +926.7K (+21.4%) vs. Q1 2026
- Total value
- $1.43M
- +$290.6K (+25.5%) vs. Q1 2026
- New holders
- 7
- 7 more added
- Sold out
- 4
- 7 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.43M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $816.6K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $944.1K |
| Q4 2023 | 25 | $692.9K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $5.27M |
| Q4 2021 | 29 | $6.36M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 879,394 | $239.2K | 0.00% | −163,990−15.7% | Reduced |
| Vanguard Capital Management LLC | 814,914 | $221.7K | 0.00% | +96,478+13.4% | Added |
| BlackRock, Inc. | 703,798 | $191.4K | 0.00% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 678,480 | $184.5K | 0.02% | +678,480 | New |
| Citadel Advisors LLC | 437,317 | $119.0K | 0.00% | +437,317 | New |
| Vanguard Fiduciary Trust Co | 419,413 | $114.1K | 0.00% | +3,525+0.8% | Added |
| Renaissance Technologies LLC | 286,608 | $78.0K | 0.00% | −197,367−40.8% | Reduced |
| State Street Corp | 200,799 | $54.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 170,274 | $46.3K | 0.00% | +56,867+50.1% | Added |
| Dearborn Partners LLC | 118,802 | $31.8K | 0.00% | +59,401+100.0% | Added |
| Lawood & Co | 75,000 | $20.4K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 65,541 | $17.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 62,610 | $17.0K | 0.00% | +62,610 | New |
| Truist Financial Corp | 48,667 | $13.2K | 0.00% | +12,000+32.7% | Added |
| Citigroup Inc | 46,043 | $12.5K | 0.00% | +46,043 | New |
| Fisher Asset Management, LLC | 43,400 | $11.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 39,378 | $10.7K | 0.00% | −11,270−22.3% | Reduced |
| Morgan Stanley | 35,198 | $9.57K | 0.00% | +80+0.2% | Added |
| Commonwealth Equity Services, LLC | 33,348 | $9.07K | 0.00% | −500−1.5% | Reduced |
| Susquehanna International Group, LLP | 28,882 | $7.86K | 0.00% | −93,713−76.4% | Reduced |
| Tower Research Capital LLC (TRC) | 27,607 | $7.51K | 0.00% | +6,558+31.2% | Added |
| Vanguard Global Advisers, LLC | 14,944 | $4.07K | 0.00% | 00.0% | Unchanged |
| Wealthcare Advisory Partners LLC | 10,000 | $2.72K | 0.00% | 00.0% | Unchanged |
| Burnham & Co LLC | 5,000 | $1.36K | 0.00% | +5,000 | New |
| Geneos Wealth Management Inc. | 3,000 | $810 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,600 | $707 | 0.00% | −1,162−30.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,000 | $272 | 0.00% | +1,000 | New |
| Barclays PLC | 721 | $196 | 0.00% | +721 | New |
| Caitlin John, LLC | 200 | $54 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 101 | $27 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 100 | $27 | 0.00% | 00.0% | Unchanged |
| DHJJ Financial Advisors, Ltd. | 80 | $22 | 0.00% | 00.0% | Unchanged |
| Napier Financial, LLC | 58 | $16 | 0.00% | 00.0% | Unchanged |
| Johnson Financial Group, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Triumph Capital Management | 2 | $1 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $0 | 0.00% | −8,096−100.0% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,233−100.0% | Sold out |
| T3 Companies, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Schneider Downs Wealth Management Advisors, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Trask Adam Roland | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |